Streptococcus pneumoniae: Elusive mechanisms of the body's defense systems

Journal of Preventive Medicine and Hygiene

Volumn 53, Issue 2, 2012, Pages 89-93

  Bondi, T ^a   Canessa, C ^a   Lippi, F ^a   Iacopelli, J ^a   Nieddu, F ^a   Azzari, C ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Antibiotic resistance; Capsular switch; Pneumonia; Serotype replacement; Streptococcus pneumoniae

Indexed keywords

AMINOGLYCOSIDE; CHLORAMPHENICOL; PNEUMOCOCCUS VACCINE;

ANTIBIOTIC RESISTANCE; BACTEREMIA; BACTERIAL CELL WALL; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL GENETICS; BACTERIAL MEMBRANE; BACTERIAL MUTATION; BACTERIAL STRAIN; BACTERIAL VIRULENCE; DISEASE CARRIER; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; GENE DELETION; GENE LOCUS; IMMUNE RESPONSE; IMMUNIZATION; INFECTION RATE; INFECTION RISK; MENINGITIS; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR DIAGNOSIS; MUTATION RATE; OTITIS; PATHOGENESIS; PENICILLIN RESISTANCE; REVIEW; SEPSIS; SEROTYPE; STREPTOCOCCUS PNEUMONIA; VIRUS ISOLATION;

ANTI-BACTERIAL AGENTS; CARRIER STATE; DRUG RESISTANCE, MICROBIAL; HUMANS; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 84864685632     PISSN: 11212233     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. Barocchi MA, Ries J, Zogaj X, et al. A pneumococcal pilus influences virulence and host inflammatory responses. Proc Natl Acad Sci USA 2006;103:2857-62.
2. Hammerschmidt S, Wolff S, Hocke A, et al. Illustration of pneumococcal polysaccharide capsule during adherence and invasion of epithelial cells. Infect Immun 2005;73:4653-67. (Pubitemid 41105621)
3. Angel CS, Ruzek M, Hostetter MK. Degradation of C3 by Streptococcus pneumonia. J Infect Dis 1994;170:600-8.
4. Chudwin DS, Artip SG, Koremblit A, et al. Correlation of serum opsonins with in vitro phagocytosis of Streptococcus pneumonia by polymorphonuclear leukocytes. J Infect Dis 1986;164: 619-26.
5. Abeyta M, Hardy GG, Yother J, et al. Genetic alteration of capsule type but not PspA type affects accessibility of surfacebound complement and surface antigens of streptococcus pneumonia. Infect Immun 2003;71:218-25. (Pubitemid 36026023)
6. Nelson AL, Roche AM, Gould JM, et al. Capsule enhances pneumococcal colonization by limiting mucus-mediated clearance. Infect Immun 2007;75:83-90. (Pubitemid 46047881)
7. Quin LR, Moore QC, McDaniel LS, et al. Pneumolisyn, PspA, and PspC contribute to pneumococcal evasion of early innate immune responses during bacteremia in mice. Infect Immun 2007;75:2067-70. (Pubitemid 46559476)
8. Hoffmann O, Braun JS, Becker D, et al. TLR2 mediates neuroinflammation and neuronal damage. J Immunol 2007;178:6476-81. (Pubitemid 46717431)
9. Albiger B, Dahlberg S, Sandgren A. Toll-like receptor 9 acts at an early stage in host defence against pneumococcal infection. Cell Microbiol 2007;9:633-44. (Pubitemid 46231970)
10. Who. Position paper. 23 march 2007, 82nd year No.12, 2007;82:93-104.
11. Steenhoff A, Shah SS, Ratner AJ, et al. Emergence of vaccinerelated pneumococcal serotypes as a cause of bacteremia. Clin Infect Dis 2006;42:907-14.
12. Coffey TJ, Dowson CG, Daniels M, et al. Horizontal transfer of multiple penicillin-binding protein genes, and capsular biosynthetic genes, in natural populations of Streptococcus pneumoniae. Mol Microbiol 1991;5:2255-60. (Pubitemid 21896258)
13. Gherardi G, Whitney CG, Facklam RR, et al. Major related sets of antibiotic-resistent pneumococci in the United States as determined by pulsed-field gel electrophoresis and pbp1a-pbp2bpbp2x-dhf restriction profile. J Infect Dis 2000;181:216-29. (Pubitemid 30049052)
14. Butler JC, Breiman RF, Lipman HB, et al. Serotype Distribution of Streptococcus pneumoniae infections among preschool children in the United States, 1978-1994: implications for development of a conjugate vaccine. J Infect Dis 1995;171:885-9.
15. th ICAAC, Chicago, September 17-20, 2007.
16. Dagan R, Givon-Lavi N, Leibovitz E, et al. Introduction and proliferation of multidrug-resistant Streptococcus pneumoniae serotype 19A clones that cause acute otitis media in an unvaccinated population. J Infect Dis 2009;199:776-85.
17. Croucher NJ, Harris SR, Fraser C, et al. Rapid pneumococcal evolution in response to clinical interventions. Science 2001;331 430-4.
18. Hanage WP, Fraser C, Tang J, et al. Hyper-ricombination, diversity, and antibiotic resistance in pneumococcus. Science 2009; 324:1454-7.
19. McGee L, Mc Dougal L, Zhou J, et al. Nomenclature of major antimicrobial-resistance clones of streptococcus pneumoniae defined by the pneumococcal molecular epidemiology network. J Clin Microbiol 2001;39:2565-71. (Pubitemid 32606233)
20. Brueggemann AB, Pai R, Crook DW, et al. Vaccine Escape recombinants emerge after pneumococcal vaccination in the United States. Plos Pathogens 2007;3:1628-36. (Pubitemid 350291600)
21. Huang SS, Platt R, Rifas-Shiman SL, et al. Post-PCV7 Changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004. Pediatrics 2005;113:408-13.
22. Huang SS, Hinrichsen VL, Stevenson AE, et al. Continued impact of pneumococcal conjugate vaccine on carriage in young children. Pediatrics 2009;124:1-11.
23. Werno AM, Murdoch DR. Medical microbiology: laboratory diagnosis of invasive pneumococcal disease. Clin Infect Dis 2008;46:926-32. (Pubitemid 351417200)
24. Lipsitch M, O'Neill K, Cordy D, et al. Strain characteristics of Streptococcus pneumoniae carriage and invasive disease isolates during a cluster-randomized clinical trial of the 7-valent pneumococcal conjugate vaccine. J Infect Dis 2007;196:1221-7. (Pubitemid 47580277)